ASA and CAP Rules for Cosmetic Surgery Marketing: A Practical Guide

Why ASA and CAP Compliance Matters for Cosmetic Surgery Marketing

The Advertising Standards Authority (ASA) and the Committee of Advertising Practice (CAP) regulate all advertising in the UK, including the marketing of cosmetic surgery and aesthetic medicine services. For clinic owners and practitioners, this is not a niche concern — non-compliance can result in formal ASA rulings published on the ASA website, mandatory withdrawal of advertising, significant reputational damage, and in serious or persistent cases, referral to Trading Standards, the GMC, the NMC, or other regulatory bodies.

Cosmetic surgery and aesthetics advertising is held to a higher standard than most industries because the ASA and CAP recognise that patients in this sector are often in a vulnerable emotional state, that advertising can exploit body image anxieties, and that the consequences of inappropriate procedures can be irreversible. This is why the rules are stricter for cosmetic treatments than for most consumer products and services.

CAP is the industry body that writes and maintains the UK Advertising Codes — the CAP Code covers non-broadcast advertising (websites, social media, email, printed materials) and the BCAP Code covers broadcast advertising (television and radio). The ASA is the independent regulator that enforces these codes. When a complaint is upheld, the ruling is published publicly and the advertiser must amend or withdraw the material immediately.

Key CAP Code Sections for Aesthetics Advertising

Several sections of the CAP Code are directly relevant to aesthetic clinic and cosmetic surgery marketing. Understanding which rules apply — and why — is the foundation of a compliant content strategy.

Section 12: Medicines, Medical Devices, Health-Related Products and Beauty Products

Section 12 is arguably the most important for aesthetic clinics. It governs claims about treatments that affect health, appearance, or wellbeing. Key provisions include: advertising must not claim that a product or service is safe if it is not; advertising must not claim or imply miraculous results; health claims must be substantiated by credible evidence; and advertisements for prescription-only medicines (POMs) directed at the general public are prohibited.

This last point is critical. Botulinum toxin — sold under brand names including Botox, Azzalure, and Bocouture — is a prescription-only medicine. You cannot advertise it to the public by its brand name as a treatment available to purchase. You can describe "anti-wrinkle injections" or "wrinkle-relaxing treatments" in factual terms, but promoting "Botox" as though it were a retail product breaches Section 12. This is one of the most common compliance failures in UK aesthetic marketing, and it is actively enforced.

Section 3: Misleading Advertising

Section 3 prohibits advertising that is likely to mislead consumers through inaccurate statements, material omissions, or exaggerated claims. For aesthetic clinics: before-and-after results must represent realistic, achievable outcomes for a typical patient and not cherry-picked best cases; pricing must be transparent and inclusive of all associated costs; treatment descriptions must accurately reflect what the procedure involves and what recovery requires; and practitioner qualifications claimed in advertising must be genuine and verifiable.

Section 4: Harm and Offence

Section 4 prohibits advertising that is likely to cause harm or serious or widespread offence. For aesthetics, this includes advertising that exploits body image insecurities, targets people with low self-esteem in a manipulative way, or creates unrealistic expectations about physical appearance. The ASA has upheld complaints against clinics whose advertising implied that natural physical features were flaws requiring correction — a higher standard than many clinic owners realise.

Specific Aesthetics Provisions

The CAP Code also includes provisions specifically for cosmetic interventions. These prohibit: offering inducements — including discounts, countdown timers, and "last appointment" pressure tactics — that encourage hasty decision-making about cosmetic procedures; advertising that targets or appeals to under-18s for cosmetic treatments; and techniques designed to exploit the insecurities of vulnerable audiences. Any promotional offer on a cosmetic treatment needs to be assessed against these provisions before going live.

Before-and-After Imagery Rules

Before-and-after imagery is one of the most powerful and most regulated elements of aesthetic marketing. The rules differ significantly between paid advertising and organic content, and misunderstanding this distinction is one of the most common compliance failures among UK aesthetic clinics.

Paid Advertising: Before-and-After Images Are Prohibited

The CAP Code prohibits the use of before-and-after imagery in paid advertising for cosmetic surgery and injectable procedures. This applies to Google Ads, Facebook Ads, Instagram Ads, TikTok Ads, and any other paid format — regardless of how the images are labelled or what disclaimers accompany them. The rationale is that paid advertising reaches audiences who have not necessarily expressed an interest in cosmetic treatments, and before-and-after images in this context can exploit body image anxieties and create undue pressure to seek interventions.

This prohibition is strictly enforced. A clinic running a paid social campaign featuring treatment before-and-after images is in breach of the CAP Code even if the results shown are genuine and all patients consented to use of their images.

Organic Content: Permitted With Conditions

Before-and-after images on your website, in unpaid social media posts, and in editorial content are generally permitted — but only when specific conditions are met. Results must be genuine and representative of realistic outcomes for typical patients, not exceptional cases selected purely because they are dramatic. The images must be accompanied by a disclaimer such as "Results may vary" or "Individual results will differ." They must not be digitally altered to exaggerate results. They must not be presented in a way that implies guaranteed outcomes or exploits the viewer's insecurities about their appearance.

Patient consent to use before-and-after images in marketing is also a GDPR requirement that is separate from clinical consent. It must be obtained in writing with clear information about how and where the images will be used, and it must be stored carefully — you will need to be able to produce it if a complaint is made.

Testimonial Restrictions for Aesthetic Marketing

Patient testimonials are a legitimate and powerful marketing tool, but the rules around their use in cosmetic surgery and aesthetic marketing are specific and must be applied carefully.

Any testimonial used in advertising must be genuine. It must accurately reflect the patient's actual experience and must not be selectively edited to create a misleading impression. Fabricated testimonials or composite quotes assembled from multiple patients' responses are straightforwardly deceptive and would constitute a serious breach of the CAP Code.

Testimonials referencing specific procedural outcomes can be problematic when they imply that all patients will achieve similar results. A quote such as "My lip filler completely transformed my face and gave me the confidence I always wanted" sits in a grey area — it references a specific result and implies a significant psychological benefit. The ASA would assess whether such a testimonial, taken in context, makes unsubstantiated outcome or wellbeing claims.

Testimonials about the clinical experience, the consultation process, the professionalism of the practitioner, and the quality of aftercare are generally less contentious — provided they are genuine. Experience testimonials carry lower regulatory risk than outcome testimonials and are often more persuasive for prospective patients in any case, as they speak to the anxiety of choosing the right clinic rather than the desire for a specific physical result.

A practical approach: use a dedicated consent form for testimonial collection that captures the patient's genuine words and obtains explicit written agreement to use them in specific marketing contexts. Store this documentation carefully — it is your evidence of compliance if a complaint is ever raised.

Outcome Claims, Wellbeing Claims, and Prohibited Language

The language used in aesthetic marketing is closely scrutinised by the ASA. Some claims are outright prohibited; others require substantiation before they can legitimately appear in advertising.

What You Cannot Do

• Make life-changing or confidence-restoring claims: Statements that a cosmetic treatment will be "life-changing," "transformative," or will "restore your confidence" make unsubstantiated psychological wellbeing claims. The ASA has upheld complaints against clinics using precisely this kind of language.
• Promise guaranteed outcomes: No aesthetic procedure guarantees a specific result. Language such as "guaranteed natural-looking results," "achieve your perfect look," or "satisfaction guaranteed" breaches Section 3 (misleading) and Section 12.
• Use pressure sales tactics on cosmetic decisions: Countdown timers on pricing pages, "book today — limited slots available" notices, and flash sale offers on cosmetic procedures are likely to breach the CAP Code provisions on inducements that encourage hasty decision-making about cosmetic interventions.
• Target under-18s: Advertising for cosmetic procedures must not be directed at audiences under 18. This applies to social media audience targeting, influencer partnerships with predominantly young audiences, and any content designed to appeal to teenagers.
• Advertise prescription-only medicines by brand name to the public: Naming botulinum toxin by its trade names (Botox, Azzalure, Bocouture) in consumer-facing advertising breaches Section 12. Describe the treatment category — anti-wrinkle injections, wrinkle-relaxing treatment — rather than naming the medicine.

What You Can Do

• Describe services factually — what the procedure involves, how long it takes, what recovery looks like, and what it is designed to achieve.
• Show before-and-after results in organic, unpaid content with appropriate consent documentation and "results may vary" disclaimers.
• Use genuine patient testimonials that focus on experience rather than specific outcomes, provided they are accurate and not misleadingly edited.
• Publish educational content about treatments, conditions, and treatment options without making outcome claims — this kind of content is highly effective for SEO and patient trust-building.
• Describe practitioner qualifications, credentials, and clinical experience accurately and in full.
• State pricing transparently and inclusively — all associated costs, consultation fees, and aftercare charges should be disclosed.

Social Media Compliance: Instagram, TikTok, and Facebook

Social media advertising for aesthetic clinics operates at the intersection of ASA/CAP rules and each platform's own community standards and advertising policies. Both sets of rules apply simultaneously — satisfying one does not mean you satisfy the other, and content that passes platform review can still be subject to ASA complaint.

Instagram and Facebook both prohibit before-and-after images in paid advertisements for cosmetic procedures, which aligns with the CAP Code. They also restrict promotion of surgical procedures and injectable treatments in paid advertising more broadly. Their policies on organic content differ from paid content rules — in line with the CAP Code position, organic posts can include before-and-after imagery with appropriate context and disclaimers.

TikTok applies its own advertising policies and community guidelines to cosmetic procedure content. Given TikTok's predominantly young user demographic, the platform has been particularly active in restricting content that promotes cosmetic surgery or unrealistic body image standards to younger audiences. Content can be removed and accounts restricted if TikTok considers it to breach these standards, regardless of whether the content would pass ASA review. Aesthetic clinics posting on TikTok need to apply particular care to both content and the implied audience.

A practical approach to social media compliance: treat all paid social advertising as subject to the most restrictive rules — no before-and-after images, no outcome claims, no pressure tactics, no prescription medicine brand names. For organic content, apply CAP Code standards plus each platform's community guidelines. Conduct a quarterly review of your social content for compliance drift, since platform policies evolve and what was permissible twelve months ago may now be restricted.

Influencer marketing is an area of particular high risk in aesthetics. The ASA requires paid partnerships with influencers to be clearly labelled as advertising. Any claim made by an influencer on your behalf must comply with the same rules that apply to your own advertising. The ASA has taken action against both brands and influencers for undisclosed partnerships and non-compliant cosmetic content — and the high follower counts involved make these cases high-profile when they occur.

Surgical vs Non-Surgical: Where the Rules Differ

The CAP Code applies to both surgical and non-surgical cosmetic procedures, but there are meaningful differences in how the rules apply in practice.

For surgical procedures — rhinoplasty, breast augmentation, facelifts, body contouring surgery — the ASA applies particular scrutiny to advertising that might encourage patients to seek surgery when less invasive alternatives might be more appropriate, or that presents surgery as low-risk or outcome-guaranteed. The more irreversible the intervention, the greater the care required in how it is described and marketed.

For non-surgical treatments including injectables, skin treatments, and laser procedures, the same core rules apply but different compliance points are most relevant. The prohibition on advertising POMs by brand name to consumers is particularly important for anti-wrinkle injections, skin boosters containing prescription-grade ingredients, and other injectable treatments. Clinics should review their website treatment pages specifically for POM brand name usage.

For body contouring treatments — fat-freezing, HIFU, radiofrequency body treatments — outcome claims are a frequent source of ASA complaints. Advertising that implies significant fat reduction or body transformation through non-surgical means without substantiation is regularly the subject of enforcement action. Claims about centimetre reduction or fat cell elimination require robust clinical evidence to be used in advertising.

The CAP Copy Advice Service

One of the most underused resources available to UK aesthetic clinics and cosmetic surgery practices is the CAP Copy Advice service. This free service allows you to submit advertising copy before publication and receive guidance on whether it is likely to comply with the CAP Code. The service is confidential, free of charge, and typically returns advice within five working days of submission.

Using copy advice is not a guarantee of compliance — the ASA makes independent judgements when complaints arise — but it demonstrates good faith and substantially reduces the risk of non-compliant advertising. For any major campaign, for new website copy making health or outcome claims, or for content in a format you are uncertain about — a new social media format, an influencer partnership, a new treatment category page — submitting for copy advice is a sound precaution.

The CAP Copy Advice service is accessible through cap.org.uk and is available to advertisers, agencies, and publishers regardless of business size. A single-site aesthetic clinic can access the same guidance as a large multi-site group. Given that a single upheld ASA ruling can cost far more in management time and reputational damage than the copy advice process would ever take, this is an unambiguously worthwhile step for any clinic running regular marketing activity.

Common Enforcement Actions and Real-World Risks

Understanding how the ASA enforces the CAP Code in practice is more useful than reading the rules in the abstract. The ASA publishes all upheld rulings on its website, and there is a substantial body of decisions specifically relating to cosmetic surgery and aesthetic clinic advertising that UK practitioners can learn from without having to experience enforcement first-hand.

Recurring reasons for upheld rulings in the aesthetics sector include: use of before-and-after images in paid social advertising; patient testimonials that imply guaranteed outcomes; brand-name prescription medicine advertising to consumers; unsubstantiated claims that procedures will "restore confidence" or be "life-changing"; countdown timer pressure tactics on treatment booking pages; and influencer partnerships that were not clearly identified as paid advertising.

When a ruling is upheld, the immediate consequence is mandatory withdrawal or amendment of the advertising. The ruling is published on the ASA website and is permanently and publicly searchable — prospective patients, journalists, and regulatory bodies can find it indefinitely. Persistent or serious non-compliance can result in referral to Trading Standards, which has powers to seek injunctions preventing continued advertising. For GMC- or NMC-registered practitioners, an ASA ruling relating to misleading advertising could potentially be raised as a fitness to practise concern with the relevant regulatory body.

The business case for preventative compliance is straightforward. A campaign that triggers an ASA complaint, requires solicitor advice, results in a published ruling, and requires reputation management activity is likely to cost far more — in time, professional fees, and brand damage — than a structured compliance review process would have required to establish and maintain.

Building Compliance Into Your Content Workflow

The most effective approach to ASA/CAP compliance is to embed it into your content production process as a standard step, rather than treating it as an afterthought or a one-off legal review conducted annually.

Before creating any content, identify whether it will be paid or organic — this determines which rules apply with greatest force. Identify whether the content makes health claims, outcome claims, or wellbeing claims, as each of these requires substantiation or revision before publication. Check whether any brand names used refer to prescription-only medicines that cannot be advertised by name to consumers.

During content creation, run every piece through a short compliance checklist: Does the copy imply guaranteed results? Does it name prescription-only medicines by brand in a consumer-facing context? Does it use before-and-after imagery in a paid format? Does it use pressure tactics, countdown timers, or time-limited offers? Does it target or clearly appeal to under-18s? If any answer is yes, revise the content before publication.

Before publishing paid advertising or significant new organic content, review against the CAP Code. For major campaigns or content addressing new treatment categories, submit to the CAP Copy Advice service. For testimonials and before-and-after imagery, confirm written consent documentation is filed before the content goes live.

Quarterly, audit all live advertising — social media profiles, website pages, email marketing sequences, any active influencer partnerships — for compliance with current rules. Assign clear accountability for compliance sign-off within your team, whether that is a practice manager, marketing lead, or external agency partner.